The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Mapping of genetic modifiers of Nr2e3 rd7/rd7 that suppress retinal degeneration and restore blue cone cells to normal quantity
Abstract
The retinal degeneration 7 (rd7) mouse, lacking expression of the Nr2e3 gene, exhibits retinal dysplasia and a slow, progressive degeneration due to an abnormal production of blue opsin-expressing cone cells. In this study we evaluated three strains of mice to identify alleles that would slow or ameliorate the retinal degeneration observed in Nr2e3 (rd7/rd7) mice. Our studies reveal that genetic background greatly influences the expression of the Nr2e3 (rd7/rd7) phenotype and that the inbred mouse strains CAST/EiJ, AKR/J, and NOD.NON-H2 (nb1) carry alleles that confer resistance to Nr2e3 (rd7/rd7)-induced retinal degeneration. B6.Cg-Nr2e3 (rd7/rd7) mice were outcrossed to each strain and the F(1) progeny were intercrossed to produce F(2) mice. In each intercross, 20-24% of the total F(2) progeny were homozygous for the Nr2e3 (rd7/rd7) mutation in a mixed genetic background; approximately 28-48% of the Nr2e3 (rd7/rd7) homozygotes were suppressed for the degenerative retina phenotype in a mixed genetic background. The suppressed mice had no retinal spots and normal retinal morphology with a normal complement of blue opsin-expressing cone cells. An initial genome scan revealed a significant association of the suppressed phenotype with loci on chromosomes 8 and 19 with the CAST/EiJ background, two marginal loci on chromosomes 7 and 11 with the AKR/J background, and no significant QTL with the NOD.NON-H2 (nb1) background. We did not observe any significant epistatic effects in this study. Our results suggest that there are several genes that are likely to act in the same or parallel pathway as NR2E3 that can rescue the Nr2e3 (rd7/rd7) phenotype and may serve as potential therapeutic targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have shown that modifier genes, such as nuclear hormone receptors, have the potential to “reset” various networks related to retinal disease phenotypes, such as photoreceptor development, phototransduction, metabolism, cone cell development, inflammation, and cell survival, thus restoring the homeostasis in the retina to a healthy state.47,50–53”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [53]
In the citing paper
“Modifier gene therapy has the potential to alter the retinal disease state even in the absence of a genetic diagnosis or in the absence of a gene therapy specific to the mutated gene in one of these patients.47,50–53”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [53]
Citations
Cites
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results
Lander, E., & Kruglyak, L. (1995) · Nature Genetics · doi:10.1038/ng1195-241 · Cited by 5,239
R/qtl: QTL mapping in experimental crosses
Broman, K. W., Wu, H., Sen, Ś., & Churchill, G. A. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg112 · Cited by 3,463
Permutation Tests for Multiple Loci Affecting a Quantitative Character
Doerge, R. W., & Churchill, G. A. (1996) · Genetics · doi:10.1093/genetics/142.1.285 · Cited by 1,131
Cell differentiation in the retina of the mouse
Young, R. W. (1985) · The Anatomical Record · doi:10.1002/ar.1092120215 · Cited by 1,071
Nrl is required for rod photoreceptor development
Mears, A. J., Kondo, M., Swain, P. K., Takada, Y., Bush, R. A., Saunders, T. L., Sieving, P. A., & Swaroop, A. (2001) · Nature Genetics · doi:10.1038/ng774 · Cited by 912
Furukawa, T., Morrow, E. M., & Cepko, C. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80439-0 · Cited by 895
A Statistical Framework for Quantitative Trait Mapping
Sen, Ś., & Churchill, G. A. (2001) · Genetics · doi:10.1093/genetics/159.1.371 · Cited by 611
Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development
Nishida, A., Furukawa, A., Koike, C., Tano, Y., Aizawa, S., Matsuo, I., & Furukawa, T. (2003) · Nature Neuroscience · doi:10.1038/nn1155 · Cited by 604
Freund, C. L., Gregory-Evans, C. Y., Furukawa, T., Papaioannou, M., Looser, J., Ploder, L., Bellingham, J., Ng, D., Herbrick, J.-A. S., Duncan, A., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80440-7 · Cited by 565
A thyroid hormone receptor that is required for the development of green cone photoreceptors
Ng, L., Hurley, J. B., Dierks, B., Srinivas, M., Saltó, C., Vennström, B., Reh, T. A., & Forrest, D. (2001) · Nature Genetics · doi:10.1038/83829 · Cited by 561
Cited by
DSCAM and DSCAML1 Function in Self-Avoidance in Multiple Cell Types in the Developing Mouse Retina
Fuerst, P. G., Bruce, F., Tian, M., Wei, W., Elstrott, J., Feller, M. B., Erskine, L., Singer, J. H., & Burgess, R. W. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.027 · Cited by 229
“Electroretinography Dark-adapted electroretinograms were recorded as previously described (Haider et al., 2008).”
From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health
Riordan, J. D., & Nadeau, J. H. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.004 · Cited by 168
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Genetic Modifiers and Oligogenic InheritancePreprint
Kousi, M., & Katsanis, N. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017145 · Cited by 135
Schorderet, D. F., & Escher, P. (2009) · Human Mutation · doi:10.1002/humu.21096 · Cited by 111
“NON-H2nbl strains [Haider et al., 2008].”
Metadata
- Authors
- Haider, N. B., Zhang, W., Hurd, R., Ikeda, A., Nystuen, A. M., Naggert, J. K., & Nishina, P. M.
- Affiliations
- University of Nebraska Medical Center (US)
- Jackson Laboratory (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Haider, Neena B.
- Venue
- Mammalian Genome
- Published
- 2008-02-20
- Volume
- 19
- Issue
- 3
- Pages
- 145-154
- ISSN
- 0938-8990 (ISSN-L)
- 1432-1777
- OpenAlex
- W2049997790
- Cited by
- 41
- References
- 52
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2018: 2 · 2017: 2 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Mammalian Genome (publishedVersion)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- National Institutes of Health (5p20rr018788-07)
- National Eye Institute (F32EY007080, EY 11996, F32 EY07080-01A, P30EY016665, R01EY011996)
- National Cancer Institute (#CA34196, P30CA034196)
- National Center for Research Resources (5 P20 RR018788-02)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Disorders and Treatments
- Keywords
- NR2E3, retinal degeneration, genetic modifiers, retinal dysplasia, genetic background, inbred mouse strains, CAST/EiJ, quantitative trait loci, epistasis, therapeutic target
- MeSH terms
- Animals, Crosses, Genetic, Epistasis, Genetic, Mutation, Retinal Degeneration, Species Specificity, Retinal Cone Photoreceptor Cells, Receptors, Cytoplasmic and Nuclear, Mice, Orphan Nuclear Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mapping of genetic modifiers of Nr2e3 rd7/rd7 that suppress retinal degeneration and restore blue cone cells to normal quantity. https://app.cochat.ai/papers/10.1007/s00335-008-9092-2
- The paper
- Haider, N. B., Zhang, W., Hurd, R., Ikeda, A., Nystuen, A. M., Naggert, J. K., & Nishina, P. M. (2008). Mapping of genetic modifiers of Nr2e3 rd7/rd7 that suppress retinal degeneration and restore blue cone cells to normal quantity. Mammalian Genome. https://doi.org/10.1007/s00335-008-9092-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.